Delivery system

Information

  • Patent Grant
  • 7207330
  • Patent Number
    7,207,330
  • Date Filed
    Monday, June 5, 2000
    24 years ago
  • Date Issued
    Tuesday, April 24, 2007
    17 years ago
Abstract
There is described a medicament delivery device which comprises a medicament reservoir, a medicament delivery passage and a metering member adapted to transfer a measured dose of medicament from the medicament reservoir to the delivery passage characterized in that the device is provided with a moisture proof barrier. The medicament delivery device is especially suited for use as an inhaler. There is therefore also described an inhaler which provides improved airflow for the dispersion of medicament, and a method of treating patients suffering from a respiratory disorder.
Description

This application is a U.S. patent application filed under 35 U.S.C. 371, based on PCT International Application No. PCT/GB00/02017, filed Jun. 5, 2000, which claims priority to Great Britain Patent Application Nos. 9913047.8 and 9916283.6, filed Jun. 5, 1999 and Jul. 13, 1999, respectively, both of which are hereby incorporated by reference in their entirety.


FIELD OF THE INVENTION

This invention relates to a novel form of medicament delivery system and to novel methods of treatment.


In particular the invention provides a medicament delivery device, such as an inhaler, which is adapted to be moisture resistant and/or provides improved air flow through the device.


BACKGROUND OF THE INVENTION

It is well established that delivery devices adapted for the delivery of dry powder medicaments suffer from the problem of contact with moisture. Such problems are particularly when hygroscopic medicaments are used or when climatic conditions give rise to high humidity. Medicament inhalers are known to suffer from such and moisture contamination of dry powder inhalers has long been held to be undesirable since the dry powder medicament may become clogged, creating problems in delivering correct dosages of medicament. Furthermore, some inhaled medicaments are themselves inherently moisture sensitive. Therefore, there has long been a desire to provide a dry powder inhaler that is resistant to moisture, that is, one that protects a medicament reservoir from moisture contamination either from the environment or from exhalation by a patient using the device and various attempts have been made to mitigate the problem.


Most attempts which have been made aim to reduce the moisture which comes into contact with a medicament, such attempts generally comprise the use of an additional chamber containing a desiccant.


International Patent Application No WO 98/41261 describes an inhalation device which includes a chamber for containing a desiccant, e.g. silica gel. Whilst the use of a desiccant gel does remove some moisture, the system is disadvantageous in that, inter alia, the leak paths are too great for the available desiccant to cope with and therefore the desiccant is only effective for a few hours, whereas there is a need for moisture resistance if at least a few months.


Similarly, International Patent Application No WO 96/08284 describes an inhaler system provided with a reservoir wherein the closed end of the reservoir is also provided with a desiccant cartridge.


International Patent Application No WO 95/32752 also describes a medicament chamber included in an inhalation apparatus and provided with a container containing a desiccant.


European Patent Application No. EP0520 440, Ambrosio et al, describes a dry powder inhaler which includes a moisture resistant barrier in the form of a flap which is designed to prevent exhaled air from a patient contaminating the medicament held in the reservoir.


SUMMARY OF THE INVENTION

U.S. Pat. No. 3,854,626, Krechmar et al, describes a pill dispensing system which comprises a moveable mechanism which prevents the ingress of moisture whilst permitting the dispensing of one or more pills.


We have now developed a medicament delivery device, e.g. a dry powder inhaler, which is able to provide a moisture proof barrier without the necessity of a desiccant.


Therefore, according to the invention we provide a medicament delivery device which comprises a medicament reservoir, a medicament delivery passage and a metering member adapted to transfer a measured dose of medicament from the medicament reservoir to the delivery passage characterised in that the device is provided with a moisture proof barrier.


The moisture proof barrier is preferentially a physical barrier as opposed to a chemical barrier, e.g. a desiccant, although it is within the scope of the present invention that a desiccant may be included in addition to the moisture proof barrier if desirable.


In a preferred embodiment the moisture proof barrier is positioned so as to prevent the ingress of moisture into the medicament reservoir, so that moisture is prevented from coming into contact with the medicament. In an especially preferred embodiment of the delivery device of the invention, the moisture proof barrier is a moisture proof sealing means.


In a preferred embodiment, the sealing means of the delivery device will operate by the delivery device being adapted to move from an inoperable position, in which the medicament reservoir is sealed, to an operative position, in which the seal is reversibly broken so that measurement and/or delivery of a dose of medicament may take place. The sealing means will generally comprise a resilient sealing member positioned at the end of the reservoir adjacent the metering member. Furthermore, the metering member is preferentially biased towards the resilient sealing member to improve the seal provided. Preferably the resilient sealing member is in a fixed position whilst the metering member moves from an inoperable to an operable position and thus from a sealing to a non-sealing position.


The resilient sealing member preferably comprises a cover adapted to fit the base of the medicament reservoir, the sealing member being provided with an aperture to permit transmission of the medicament. The resilient sealing member may comprise any conventionally known material, for example a natural or synthetic rubber, a silicon or a PTFE material, although other similar materials can be contemplated within the scope of this invention.


The moisture proof barrier of the invention may be applied to any conventionally known medicament delivery system. However, in a preferred embodiment, the medicament delivery device is an inhaler. Whilst the moisture proof barrier may be applied to any conventionally known inhaler, it is an especially preferred aspect of the invention for the inhaler to be a dry powder inhaler (DPI). DPI's are known which operate with predetermined doses of medicament, for example, the medicament may be coned in a gelatin capsule which is ruptured to release the medicament. However, a preferred inhaler of the invention is a DPI which comprises a medicament reservoir a metering member which is adapted to measure a selected amount of medicament for inhalation. Thus, in an especially preferred embodiment the metering member is rotatable from an operable to an inoperable position. The metering member may comprise a dispensing member and a moisture resistant member, e.g. a moisture resistant sleeve. In such an embodiment the moisture resistant member is provided with one or more measure chambers adapted to measure a predetermined dosage of medicament. Thus, in the operable position, the position of measuring chamber of the metering member corresponds with the aperture in the resilient sealing member so that medicament enters the measuring chamber. The moisture resistant member may then be rotated so that the reservoir is sealed again by the wall of the moisture resistant member. At the same time the medicament is transferred from the measuring chamber of the moisture resistant sleeve to the dispensing chamber of the dispensing member.


An example of a preferred DPI is CLICKHALER, produced by Innovata Biomed in the UK. Such a device is described in European Patent No 0 539 469. Thus, the metering member may be a frusto conical member such as described in European Patent No 0 539 469.


Therefore, the metering member may comprise a frusto conical dispensing member with a corresponding moisture resistant sleeve, such that the sleeve overlies the dispensing member. Thus, the measuring chamber may comprise outer side walls which are provided by an aperture in the wall of the moisture resistant sleeve and the base of the measuring chamber may be provided by the frusto conical wall of the dispensing member. Preferably the moisture resistant sleeve is provided with a plurality of apertures and thereby a plurality of measuring chambers.


The use of the frusto-conical shape in the wall of the metering member containing the measuring chamber allows a good seal to be obtained between the metering member and a seat against which the frusto-conical wall mates.


Therefore, the frusto conical metering member may itself comprise a combination of a frusto conical dispensing member and a frusto conical moisture resist sleeve which forms a snug fit over the dispensing member. The moisture resistant sleeve may itself be moveable eg rotatable, from a sealing to a non-sealing position as herein before described and vice verse. Such a moisture resistant sleeve may comprise any conventionally known material but is preferentially a plastics material, e.g. the same material as the metering member.


The dispensing member and the moisture resistant sleeve can, preferentially, be adapted so as to act together as a medicament measuring/dispensing member. The preferred metering member comprises a dispensing member provided with one or more dispensing cups and a moisture resistant sleeve provided with one or more apertures. Preferably the dispensing member comprises a plurality of dispensing cups and the sleeve comprises a plurality of apertures. It is especially preferred that the dispensing member comprises an equivalent number of dispensing cups to apertures in the sleeve.


We have especially found that if the moisture resistant sleeve comprises a frusto hemispherical cone, then an improved seal is achieved between the medicament reservoir and the sleeve. When a frusto hemispherical cone sleeve is used, the arcuate base of the reservoir is able to make more uniform contact with the curved surface of the cone and therefore an improved seal is achieved. Thus, it is especially preferred that the outer walls of the cone which are hemispherical. Furthermore, the inner walls of the cone are preferably contoured to form a good mate with the frusto conical dispensing member.


Thus, in operation, the metering member may be moved to a first position in which the medicament is transferred to a first measuring chamber in the moisture resistant sleeve, the device is then moved to a second position in which medicament is transferred from the measuring chamber to a dispensing cup in the dispensing member and then to a third position where medicament is delivered to the delivery passage.


The dispensing member may be a conventionally known member such as a frusto conical member described herein and in EP 0 539 469. However, we have also found the use of a moisture resistant sleeve permits a dispensing chamber to be provided with an air inlet, e.g. an air duct. Previously, the use of an air inlet was felt to be undesirable since it might effect the accuracy of the measurement of the medicament dose. However, by use of a system wherein the medicament is first transferred to a measuring chamber and then subsequently to a dispensing cup, the cup in the dispensing member may be provided with an air inlet without any loss in accuracy of the dosage delivered. Furthermore, improved air flow provides greater likelihood of complete emptying of the dispensing cup and thereby provide an inhaler with improved performance. Clearly, an inhaler with such improved performance is advantageous per se, regardless of whether such an inhaler is moisture resistant.


Thus according to an alternative feature of the invention we provide a dry powder inhaler which comprises a medicament reservoir, an inhalation passage for the delivery of the medicament and a metering member adapted to transfer a measured dose of medicament from the medicament reservoir to the inhalation passage characterised in that the metering member comprises a measuring member adapted to measure a pre-defined dosage of medicament and moveable from a measuring to a non-measuring position; and a dispensing member adapted to receive the measured dosage of medicament from the measuring member and to deliver the medicament to the inhalation passage, the dispensing member being moveable from a medicament receiving position to a medicament delivering position.


In the preferred embodiment the dispensing member is provided with one or more medicament dispensing cups, said cups being provided with a duct so as to provide a flow of air through the cup and into the inhalation passage upon operation of the device.


By the term dry powder we mean a medicament in finely divided form.


A variety of medicaments may be administered by using the inhaler of the invention, optionally with a conventionally known pharmaceutically acceptable adjuvant, diluent or carrier. Such medicaments are generally antibiotics, bronchodilators or other anti-asthma drugs. Such medicaments include, but are not limited to β2-agonists, e.g. fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline; non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, e.g. theophylline, aminophylline and choline theophyllinate; anticholinergics, e.g. ipratropium bromide; mast cell stabilisers, e.g. sodium cromoglycate and ketotifen; bronchial anti-inflammatory agents, e.g. nedocromil sodium; and steroids, e.g. beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations thereof.


Specific combinations of medicaments which may be mentioned include combinations of steroids, such as, beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations of to β2-agonists, such as, formoterol and salmeterol. It is also within the scope of this invention to include combinations of one or more of the aforementioned steroids with one or more of the aforementioned β2-agonists.


The inhaler of the invention is especially suitable for use in the treatment or alleviation of respiratory disorders. Thus according to the invention we also provide a method of administering a dry powder inhalation medicament using an inhaler as hereinbefore described.


We further provide a method of treatment of a patient with a respiratory disorder which comprises the administration of a combination of medicaments using an inhaler as hereinbefore described.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will now be described by way of example only and with reference to the accompanying drawings in which:



FIG. 1 is a perspective view of an inhalation device of the invention;



FIGS. 2
a–f are schematic representations of the sealing and measuring mechanism.



FIG. 3 is a perspective view of a moisture resistant sleeve comprising a frusto hemispherical cone, and



FIGS. 4
a–b are cross-sectional views of a moisture resistant sleeve comprising a frusto herispherical cone.





DETAILED DESCRIPTION OF THE INVENTION

With reference to FIG. 1, a dry powder inhaler (1) comprises a medicament reservoir (2) comprising an essentially conical member; an inhalation passage (3) and a metering member (4). The inhalation passage (3) is connected to the medicament reservoir (2) by a reservoir support (5) ad is itself connected to recess (6) which provides a seat for the metering member (4). The metering member (4) is rotatable about an axis (7) from a medicament receiving position, to a medicament delivery position and then to an emptying position to allowing any residual medicament to be emptied into a waste box (8).


The recess (6) is essentially frusto conical in shape to enable it to provide a seal for the metering member (4). The metering member (4) comprises a frusto conical moisture resistant sleeve (9) which forms a snug fit between recess (6) and a dispensing member (10). The dispensing member (10) is also provided with a back plate (11).


The moisture resistant sleeve (9) abuts at the resilient seal (9a) to form a moisture resistant seal.


The moisture resistant sleeve (9) is also provided with a plurality of measuring chambers which comprise apertures (12) dimensioned to measure a predetermined amount of medicament and to fit over cups (13) in the dispensing member (10). In a preferred embodiment, each of the cups (13) are also provided with a duct (14). The medicament reservoir (2) is also provided with a moisture resistant, eg foil, cover (15) at it's end (16) distal from the metering member (4).


With reference to FIG. 2, in which FIG. 2a the metering device is in a closed position,



FIG. 2
b the metering device is in a measuring position,



FIG. 2
c the metering device is in a seal transitory position,



FIG. 2
d the metering device is in a medicament transfer position,



FIG. 2
e the metering device is in a medicament delivery position; and



FIG. 2
f the metering device is returned to the closed position.


In FIG. 2a the metering device (4) is in the closed position and the medicament reservoir (2) is isolated and a seal formed between the sealing member (17) and the surface (18) of the moisture resistant sleeve (9). In FIG. 2b, the moisture resistant sleeve (9) is rotated in an anti clockwise direction so that the aperture/measuring chamber (12) corresponds with the aperture in the sealing member (17). The aperture/measuring chamber (12) forms a cup with the surface of the dispensing member (10).


In FIG. 2c the moisture resistant sleeve (9) is further rotated so that the aperture/measuring chamber (12) sits below the sealing member (17). The internal edge of the sealing member (17) scrapes any excess medicament from the aperture/measuring chamber (12) to leave a measured dose.


In FIG. 2d the dispensing member (10) is rotated in an anticlockwise direction so that the dispensing cup (13) corresponds with the aperture/measuring chamber (12) allowing medicament to transfer from the aperture/measuring chamber (12) to the dispensing cup (13).


In FIG. 2e both the dispensing member (10) and the moisture resistant sleeve (9) are rotated anticlockwise to expose them and the medicament to the inhalation passage (3). The patient can then inhale the medicament.


In FIG. 2f the inhalation device remains in the close position ready for use.


With reference to FIGS. 3 and 4, a moisture resistant sleeve (9) comprises a frusto hemispherical cone (22) wherein the outer surface (23) is arcuate. The inner surface (24) acts as a female member to form a snug fit with the frusto conical dispensing member (10). Downward pressure in the medicament reservoir (2) ensures a constant moisture tight seal between the sealing member (17) and the frusto hemispherical cone (22). Furthermore, referring to FIG. 4c, the leading edge (25) of the sealing member (17) is capable of acting as a scraper or a cleaning edge, removing any excess medicament from the measuring chamber upon rotation of the metering member.


A variety of mechanisms may be used for the operation of the inhaler. One preferred mechanism is for movement from the closed to the measuring position to be achieved by removal of a month piece which is operably linked to the moisture resistor. Movement from the measuring position to the transitory position would use a mechanism similar to that described in EP 0 539 469, e.g. by depressing the button half way. Movement to the transfer position being achieved by further depressing the button, and then depression completely, moving the metering cone and the moisture resistor to the delivery position.

Claims
  • 1. A medicament delivery device comprising: a medicament reservoir;an inhalation passage; anda metering member, provided with at least one dispensing cup, adapted to transfer a measured dose of medicament from the medicament reservoir to a medicament delivery position;
  • 2. A medicament delivery device according to claim 1, characterized in that the device is provided with a moisture proof barrier.
  • 3. The delivery device according to claim 1 or 2 wherein said metering member comprises a moisture resistant sleeve.
  • 4. The delivery device according to claim 3 wherein at least one aperture in said sleeve provides said at least one measuring chamber.
  • 5. An inhaler comprising: a medicament reservoir;an inhalation passage; anda metering member, provided with at least one dispensing cup, adapted to transfer a measured dose of medicament from the medicament reservoir to a medicament delivery position;
  • 6. An inhaler according to claim 5 characterized in that the metering member comprises an outer sleeve and a dispensing member.
Priority Claims (2)
Number Date Country Kind
9913047.8 Jun 1999 GB national
9916283.6 Jul 1999 GB national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/GB00/02017 6/5/2000 WO 00 5/20/2002
Publishing Document Publishing Date Country Kind
WO00/74754 12/14/2000 WO A
US Referenced Citations (140)
Number Name Date Kind
1858735 Goodsell May 1932 A
2587215 Priestly Feb 1952 A
3008609 Sessions Nov 1961 A
3439823 Morane Apr 1969 A
3798054 Kawata et al. Mar 1974 A
3854626 Krechmar Dec 1974 A
3874381 Baum Apr 1975 A
3876269 Fisher et al. Apr 1975 A
4047635 Bennett, Jr. Sep 1977 A
4114615 Wetterlin Sep 1978 A
4174034 Hoo Nov 1979 A
4200099 Guenzel et al. Apr 1980 A
4274403 Struve Jun 1981 A
4524769 Wetterlin Jun 1985 A
4534343 Nowacki et al. Aug 1985 A
4570630 Elliott et al. Feb 1986 A
4604847 Moulding, Jr. et al. Aug 1986 A
4624442 Duffy et al. Nov 1986 A
4627432 Newell et al. Dec 1986 A
4635829 Brittingham, Jr. Jan 1987 A
4668218 Virtanen May 1987 A
4811731 Newell et al. Mar 1989 A
4860740 Kirk et al. Aug 1989 A
4882210 Romberg et al. Nov 1989 A
4895719 Radhakrishnan et al. Jan 1990 A
4907583 Wetterlin et al. Mar 1990 A
4934358 Nilsson et al. Jun 1990 A
4950365 Evans Aug 1990 A
5002048 Makiej, Jr. Mar 1991 A
5007419 Weinstein et al. Apr 1991 A
5042472 Bunin Aug 1991 A
5053237 Hendricks et al. Oct 1991 A
5064083 Alexander et al. Nov 1991 A
5067491 Taylor, II et al. Nov 1991 A
5113855 Newhouse May 1992 A
5152422 Springer Oct 1992 A
5154326 Chang et al. Oct 1992 A
5161524 Evans Nov 1992 A
5169029 Behar et al. Dec 1992 A
5192528 Radhakrishnan et al. Mar 1993 A
5201308 Newhouse Apr 1993 A
5207217 Cocozza et al. May 1993 A
5208226 Palmer May 1993 A
5253782 Gates et al. Oct 1993 A
5263475 Altermatt et al. Nov 1993 A
5295479 Lankinen Mar 1994 A
5301666 Lerk et al. Apr 1994 A
5320714 Brendel Jun 1994 A
5347999 Poss et al. Sep 1994 A
5351683 Chiesi et al. Oct 1994 A
5394868 Ambrosio et al. Mar 1995 A
5409132 Kooijmans et al. Apr 1995 A
5411175 Armstrong et al. May 1995 A
5415162 Casper et al. May 1995 A
5435301 Herold et al. Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5437270 Braithwaite Aug 1995 A
5447151 Bruna et al. Sep 1995 A
5450160 Tianello et al. Sep 1995 A
5458135 Patton et al. Oct 1995 A
5485939 Tucker Jan 1996 A
5503144 Bacon Apr 1996 A
5520166 Ritson et al. May 1996 A
5524613 Haber et al. Jun 1996 A
5551597 Lambelet, Jr. et al. Sep 1996 A
5562231 Lambelet, Jr. et al. Oct 1996 A
5562918 Stimpson Oct 1996 A
5575280 Gupte et al. Nov 1996 A
5617845 Poss et al. Apr 1997 A
5622166 Eisele et al. Apr 1997 A
5653227 Barnes et al. Aug 1997 A
5657748 Braithwaite Aug 1997 A
5657794 Briner et al. Aug 1997 A
5664557 Makiej, Jr. Sep 1997 A
5664697 Lambelet, Jr. et al. Sep 1997 A
5676130 Gupte et al. Oct 1997 A
5678538 Drought Oct 1997 A
D389570 Savolainen Jan 1998 S
5740792 Ashley et al. Apr 1998 A
5740794 Smith et al. Apr 1998 A
5775536 Lambelet, Jr. et al. Jul 1998 A
5778873 Braithwaite Jul 1998 A
5785049 Smith et al. Jul 1998 A
5799821 Lambelet, Jr. et al. Sep 1998 A
5857457 Hyppölä Jan 1999 A
5875776 Vaghefi Mar 1999 A
5881719 Gottenauer et al. Mar 1999 A
5896855 Hobbs et al. Apr 1999 A
5904139 Hauser May 1999 A
5921237 Eisele et al. Jul 1999 A
5924417 Braithwaite Jul 1999 A
5941241 Weinstein et al. Aug 1999 A
5944660 Kimball et al. Aug 1999 A
5955439 Green Sep 1999 A
5981549 Viner Nov 1999 A
5996577 Ohki et al. Dec 1999 A
6006747 Eisele et al. Dec 1999 A
6035463 Pawelzik et al. Mar 2000 A
6065471 Schaeffer et al. May 2000 A
6065472 Anderson et al. May 2000 A
6089227 Nilsson Jul 2000 A
6116238 Jackson et al. Sep 2000 A
6116239 Volgyesi Sep 2000 A
6119688 Whaley et al. Sep 2000 A
6125844 Samiotes Oct 2000 A
6158675 Ogi Dec 2000 A
6196218 Voges Mar 2001 B1
6220243 Schaeffer et al. Apr 2001 B1
6234167 Cox et al. May 2001 B1
6240918 Ambrosio et al. Jun 2001 B1
6254854 Edwards et al. Jul 2001 B1
6273085 Eisele et al. Aug 2001 B1
6321747 Dmitrovic et al. Nov 2001 B1
6324428 Weinberg et al. Nov 2001 B1
6325241 Garde et al. Dec 2001 B1
6328034 Eisele et al. Dec 2001 B1
6347629 Braithwaite Feb 2002 B1
6418926 Chawla Jul 2002 B1
6443146 Voges Sep 2002 B1
6484718 Schaeffer et al. Nov 2002 B1
6523536 Fugelsang et al. Feb 2003 B2
6543443 Klimowicz et al. Apr 2003 B1
6553987 Davies Apr 2003 B1
6557550 Clarke May 2003 B1
6557552 Cox et al. May 2003 B1
6601729 Papp Aug 2003 B1
6675839 Braithwaite Jan 2004 B1
6698425 Widerström Mar 2004 B1
6810873 Haikarainen et al. Nov 2004 B1
6810874 Koskela et al. Nov 2004 B1
6845772 Braithwaite et al. Jan 2005 B2
6926003 Seppälä Aug 2005 B2
20030075172 Johnson et al. Apr 2003 A1
20030116157 Braithwaite et al. Jun 2003 A1
20030136406 Seppala Jul 2003 A1
20040011357 Braithwaite Jan 2004 A1
20040101482 Sanders May 2004 A1
20040236282 Braithwaite Nov 2004 A1
20040251318 Braithwaite Dec 2004 A1
20050121023 Braithwaite Jun 2005 A1
Foreign Referenced Citations (60)
Number Date Country
14 98 398 Jan 1969 DE
23 46 730 Apr 1975 DE
32 43 731 May 1984 DE
195 30 240 Feb 1997 DE
197 57 207 Jun 1999 DE
0 045 522 Feb 1982 EP
0 079 478 May 1983 EP
0 166 294 Oct 1989 EP
0 469 814 Feb 1992 EP
0 514 085 Nov 1992 EP
0 520 440 Dec 1992 EP
0 372 777 Jan 1993 EP
0 539 469 May 1993 EP
0 424 790 Aug 1993 EP
0 626 689 Nov 1994 EP
0 548 605 Jan 1995 EP
0 448 204 Apr 1995 EP
0 659 432 Jun 1995 EP
0 663 815 Jul 1995 EP
2 516 387 May 1983 FR
2 584 604 Jan 1987 FR
2 662 936 Dec 1991 FR
2 753 791 Mar 1998 FR
3908 Mar 1911 GB
1 242 211 Aug 1971 GB
1 573 551 Aug 1980 GB
2 041 763 Sep 1980 GB
2 165 159 Apr 1986 GB
2 178 965 Feb 1987 GB
2 235 753 Mar 1991 GB
2 248 400 Apr 1992 GB
WO 9007351 Jul 1990 WO
WO 9104011 Apr 1991 WO
WO 9111173 Aug 1991 WO
WO 9111495 Aug 1991 WO
WO 9114422 Oct 1991 WO
WO 9200771 Jan 1992 WO
WO 9203175 Mar 1992 WO
WO 9204928 Apr 1992 WO
WO 9209322 Jun 1992 WO
WO 9218188 Oct 1992 WO
WO 9300951 Jan 1993 WO
WO 9311746 Jun 1993 WO
WO 9316748 Sep 1993 WO
WO 9500128 Jan 1995 WO
WO 951577 Jun 1995 WO
WO 9700399 Jan 1997 WO
WO 9826828 Jun 1998 WO
WO9830262 Jul 1998 WO
WO 9831352 Jul 1998 WO
WO 9912597 Mar 1999 WO
WO 9913930 Mar 1999 WO
WO 9926676 Jun 1999 WO
WO 0012163 Mar 2000 WO
WO 0045878 Aug 2000 WO
WO 0064519 Nov 2000 WO
WO 0117595 Mar 2001 WO
WO 0151030 Jul 2001 WO
WO 0160341 Aug 2001 WO
WO 0187378 Nov 2001 WO